Luminita Ruby
Director, Market Access Strategy and Marketing at Alkermes | Bedford, Massachusetts, United States
Luminita Ruby’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Luminita Ruby works as the Director of Market Access Strategy and Marketing at Alkermes, where she leverages the company’s neuroscience expertise to advance treatments for complex psychiatric and neurological disorders. She earned her degree from Brandeis University and directs strategic market access initiatives aligned with the organization’s patient-inspired commercial infrastructure. Her professional focus centers on optimizing the accessibility and launch strategy for medications targeting chronic conditions such as addiction, serious mental illness, and sleep disorders.
BEST APPROACH TO REACH Luminita Ruby
Reach out via LinkedIn InMail with a concise message referencing Alkermes’ recent market access priorities or upcoming pipeline launches to initiate a targeted conversation about commercial collaboration or recruiting opportunities.
Director, Market Access Strategy and Marketing at Alkermes in July 2019 - Present
Associate Director, Payer Marketing at Alkermes in August 2014 - July 2019
Senior Product Manager at Aegerion Pharmaceuticals in August 2013 - August 2014
Senior Product Manager - Endocrinology at EMD Serono - US Subsidiary Merck Serono in July 2006 - July 2013
Brand Executive at Jurnalul National in January 2004 - August 2005
Brandeis University, MBA, July 2026
Academia de Studii Economice din București, Diploma Degree, July 2026
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders, including addiction, serious mental illness and sleep disorders. With our portfolio of marketed medicines and investigational pipeline candidates, we seek to make a meaningful difference the way people manage these chronic diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions. Our core values also guide and define our culture and contribute to our recognition as an employer of choice in the biotech industry. In 2025, Alkermes was proud to be recognized as: - A Best Workplace in BioTech and Pharmaceuticals by Fortune Magazine; - A Top Place to Work in Massachusetts by the Boston Globe; - A Best Place to Work in Ireland by the Sunday Times Ireland; and - A Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier Alkermes is headquartered in Ireland, and also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Discover more about Alkermes
CMC | Drug product development | Project management | CDMO management | Small molecule | Solid dosage form | ASD
Principal Scientist at Alkermes
(June 2025 – Present)
Strategic and results-oriented Sales & Marketing Leader
Associate Director of Marketing at Alkermes
(June 2025 – Present)
Associate Principal Scientist
Associate Principal Scientist at Alkermes
(January 2024 – Present)
Senior Director, Business Development at Alkermes
Senior Director at Alkermes
(March 2024 – Present)
Market Access | Marketing | Sales | Strategy
Associate Director, Market Access, Strategy and Marketing at Alkermes
(August 2020 – Present)
Senior Director, Product Communications and Advocacy at Alkermes
Senior Director, Serious Mental Illness and Addiction Communications and Advocacy, Corporate Affairs at Alkermes
(July 2021 – Present)
What is Luminita Ruby email address?
Email Luminita Ruby at [email protected], [email protected] and [email protected]. This email is the most updated Luminita Ruby's email found in 2026.
What is Luminita Ruby phone number?
Luminita Ruby phone number is 6174171921.
How to contact Luminita Ruby?
To contact Luminita Ruby send an email to [email protected], [email protected] or [email protected]. If you want to call Luminita Ruby try calling on 6174171921. (updated on September 14, 2025)
What company does Luminita Ruby work for?
Luminita Ruby works for Alkermes.
What is Luminita Ruby's role at Alkermes?
Luminita Ruby is Director, Market Access Strategy and Marketing
What industry does Luminita Ruby work in?
Luminita Ruby works in the Pharmaceuticals industry.
